Iceland - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Iceland Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use rose 4.9% year on year. With 110.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 4 among other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use. Iceland is overtaken by United Kingdom, which was number 3 with 116.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Portugal at 103 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands ranked the highest with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 3.9% versus 2018. Canada recorded the best 5 years average growth at +11.3% per year, while Austria recorded the worst performance at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 110.10 |
| 2018 | 107.60 |
| 2017 | 104.30 |
| 2016 | 99.10 |
| 2015 | 92.30 |
How does Iceland rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data |
| 3 |
#3
United Kingdom
|
116 | 2019 | +3.1 % | +3.4 % | View data |
| 4 |
#4
Iceland
|
110 | 2019 | +2.3 % | +4.8 % | View data |
| 5 |
#5
Portugal
|
103 | 2019 | +10.5 % | +2.2 % | View data |